Michael Beauvais Named One of Insider’s 13 “Power-Player” Life Sciences Lawyers

Practices: Life Sciences, Life Sciences Licensing, Collaborations & Joint Ventures, Health Care, Digital Health, Mergers & Acquisitions, Intellectual Property, Health Care Finance & Restructuring, Private Equity, Venture Capital & Emerging Companies

Life sciences partner Michael Beauvais (Boston) was named one of Insider’s 13 “Power-Player” Life Sciences Lawyers. 

Mike is the immediate past co-chair of Ropes & Gray's life-sciences and healthcare industry group. He advised clients, including Blackstone and Bain Capital in private equity-backed life sciences deals, and also guides life sciences companies in strategic collaborations and work to accelerate research and support drug discovery and development. 

Insider notes that Mike has led nearly three dozen deals in the past two years worth a total of $15.6 billion. He advised companies on transactions including collaborations, asset sales, and IPOs. 

His work include advising investment management leader Blackstone, whose Blackstone Life Sciences has been investing in therapeutic treatments and collaborations. In April 2020, Mike advised Blackstone in a $2 billion collaboration with Alnylam Pharmaceuticals, an RNA-treatment company.  Michael also advises earlier-stage companies, including SmartLabs, which raised $250 million in Series B financing. 

Cookie Settings